Skip to main content

3 Result(s)

within Roy L. Hawke Remove this filter

and

  1. No Access

    Article

    Antimycotic Drug Discovery in the Age of Genomics

    Genomic-based methodologies are increasingly used at all stages of drug development. The most extensive applications have occurred in early drug discovery stages due to advances in technologies that allow for ...

    Dr John D. Cleary, Larry A. Walker, Roy L. Hawke in American Journal of Pharmacogenomics (2005)

  2. No Access

    Article

    Twenty-four hour tolbutamide plasma concentration as a phenotypic measure of CYP2C9 activity

    Craig R. Lee, Roy L. Hawke, John A. Pieper in European Journal of Clinical Pharmacology (2005)

  3. No Access

    Article

    Gemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancer

    Gemcitabine administered at a fixed dose rate of 10 mg/m2 per min has been reported to achieve plasma steady-state concentrations ranging from 10 to 20 μM in patients with acute leukemia. These concentrations hav...

    Stacy S. Shord, Stephanie R. Faucette… in Cancer Chemotherapy and Pharmacology (2003)